In the past five decades, the country overall has seen an upward trend in people living longer. But it seems that for all the advances in Rheumatoid Arthritis drugs and treatments, there have been no improvements in lifespan for people with RA. New research published in the journal Arthritis & Rheumatism has found that despite much... Read more
Tumor necrosis factor inhibitors such as etanercept (Enbrel) or infliximab (Remicade) are some of the newest and most expensive drugs available to treat rheumatoid arthritis. Because they are so effective for many people with RA, the numbers of people taking them has been growing significantly over the last few years, despite the very high cost of... Read more
Rheumatologists are frequently required to evaluate the functional disability of their patients for employers, disability attorneys, insurance companies and government agencies. The evaluations are used to determine eligibility for disability payments, employment accommodations, or for certificates of need for durable medical equipment and... Read more
Last year, I wrote about research finding links between stress and depression and increased rheumatoid arthritis disease activity. Now, new research presented this month at the annual convention of the American Psychological Association shows that chronic stress can exacerbate inflammation and increases a person's risk of developing autoimmune... Read more
Researchers have found a link between hydroxychloroquine and a decreased risk of developing type-2 diabetes. Hydroxychloroquine has been in use for approximately 50 years. It was first developed as an anti-malaria drug, and then as treatment for rheumatoid arthritis, lupus and other rheumatic diseases. In type-2 diabetes, the formerly... Read more